INTC
40
-4
IRM
52
2
KLAC
53
-3
SLB
53
-3
WM
82
2
VTR
55
8
NEE
59
5
LB
60
4
AMT
45
2
DOV
69
2
CVS
52
-6
DNB
82
-2
MHK
50
-5
KHC
20
2
LYB
41
-2
JWN
59
2
RF
67
-2
BWA
48
-5
FTI
84
2
DHI
52
-4
INTC
40
-4
IRM
52
2
KLAC
53
-3
SLB
53
-3
WM
82
2
VTR
55
8
NEE
59
5
LB
60
4
AMT
45
2
DOV
69
2
CVS
52
-6
DNB
82
-2
MHK
50
-5
KHC
20
2
LYB
41
-2
JWN
59
2
RF
67
-2
BWA
48
-5
FTI
84
2
DHI
52
-4
Financhill
Back

P3 Health Partners Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
33

PIII
P3 Health Partners

Last Price:
0.25
Seasonality Move:
-42.91%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.22
Seasonality Move:
14.88%
Sell
33
P3 Health Partners (PIII) is a Sell

Is P3 Health Partners a Buy, Sell or Hold?

  • The current P3 Health Partners [PIII] share price is $0.24. The Score for PIII is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PIII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PIII Stock Price Chart

What is P3 Health Partners's stock price today?

  • The P3 Health Partners share price today is $0.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIII is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PIII Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 36.77 Sell
Chaikin Money Flow: 469860 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.23 - 0.41) Sell
Bollinger Bands (100): (0.33 - 0.57) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

PIII Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.22 Buy
20-day SMA: 0.3 Sell
50-day SMA: 0.35 Sell
200-day SMA: 0.59 Sell
8-day EMA: 0.23 Buy
20-day EMA: 0.28 Sell
50-day EMA: 0.35 Sell
200-day EMA: 0.67 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

P3 Health Partners Earnings Growth & PIII Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.42 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

P3 Health Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):